Gracell Biotechnologies Inc.

Ladies and gentlemen, thank you for standing by. Welcome to Grace Albiotechnology's third quarter 2023 conference call. At this time, all participants are in a listen-only mode. After opening remarks, we will open the call for questions. Instructions for queuing up will be given at that time. I will now turn the conference call over to Dr. Kevin Shea, Chief Financial Officer. Please go ahead.

Good morning, and welcome to Gristel's third quarter 2023 corporate update conference call and webcast. With me today are Gristel's founder and chief executive officer, Dr. William Tao, and our chief medical officer, Dr. Wendy Li. We're excited to discuss the advancement of the trials underway with our CAR-T candidates on today's call. We're looking forward to sharing with you our recent business developments and upcoming objectives as we have six weeks remaining in 2023 and are looking forward to 2024. As a reminder, we'll conduct a question and answer session following our formal remarks. This morning, Grisel issued a price release announcing unaudited financial results for the third quarter ended September 30, 2023. We encourage everyone to read this price release and would like to remind you that this call is being recorded for replay. Please note that for certain information discussed on the call today, including financial data, clinical data, future plans of our program, resource management will be making forward-looking statements. Actual results should differ materially from those stated or implied by those forward-looking statements as a result of various important factors. And please refer to the risk factors section of our latest 20F filing with SEC for a full disclosure of this risk and the factors. This conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, November 13, 2023. Green Cell undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by applicable securities law. I will now turn the call over to Green Cell CEO, Dr. William Tao.

William?